Logo
x

Search

Subscribe Now

Bausch Health

Bausch Health Reports Results from the P-II Trial of Amiselimod for the Treatment of Ulcerative Colitis

Bausch Health Reports Results from the P-II Trial of Amiselimod for the Treatment of Ulcerative Colitis

  • December 23, 2023
Bausch Health Launches Trulance (plecanatide) for the Treatment of Irritable Bowel Syndrome with Constipation in Canada

Bausch Health Launches Trulance (plecanatide) for the Treatment of Irritable Bowel Syndrome with Constipation in Canada

  • February 9, 2022
PharmaShots' Key Highlights of Second Quarter 2021

PharmaShots' Key Highlights of Second Quarter 2021

  • July 7, 2021
ADQ to Acquire Amoun Pharmaceutical from Bausch Health for ~$740M

ADQ to Acquire Amoun Pharmaceutical from Bausch Health for ~$740M

  • April 1, 2021
PharmaShots' Most Read News of 2020

PharmaShots' Most Read News of 2020

  • January 6, 2021
PharmaShots Weekly Snapshot (Nov 23 - 27, 2020)

PharmaShots Weekly Snapshot (Nov 23 - 27, 2020)

  • November 27, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.